Follow-The-Filings

Security · featured owners

CAPR

Capricor Therapeutics Inc. Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.8%
  • $6M
  • 1 exit

CAPR (Capricor Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (0.76%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.8% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors 0.76%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 0.76% Hold 229,763 $6M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0.01% Exit −0.01% 41,000 $1M history

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,2.03 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Jun 25, 2026 · 2 forms Filing Doc
4 Period Jun 22, 2026 · 2 forms Filing Doc
4 Period May 26, 2026 Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period May 13, 2026 Filing Doc
4 Period May 1, 2026 · 2 forms Filing Doc
4 Period Apr 2, 2026 Filing Doc
4 Period Mar 31, 2026 · 3 forms Filing Doc
4 Period Dec 30, 2025 Filing Doc
4 Period Jan 5, 2026 · 10 forms Filing Doc
4 Period Dec 19, 2025 Filing Doc

Updated 22 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $25.18M $22.27M $0M
Net income -$22.29M -$40.47M -$105.04M
Net margin * -88.5% -181.7% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $50.86M $163.39M $322.94M
Total non-current assets * $7.88M $7.1M $33.01M
Total assets $58.73M $170.48M $355.95M
Total current liabilities $31.27M $21.03M $35.84M
Total non-current liabilities $4.86M $3.99M $14.32M
Total equity $22.6M $145.46M $305.79M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$25.6M -$40M -$69.81M
Cash from investing $5.11M -$116.18M $97.48M
Cash from financing $25.58M $152.77M $248.89M
Net change in cash * $5.09M -$3.41M $276.56M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders